Skip to main content
. 2015 Mar 17;10(3):e0119832. doi: 10.1371/journal.pone.0119832

Fig 1. EGFR-TKI and AUY922 cytotoxicity in parental HCC827 and resistant cell lines.

Fig 1

Cells were treated with the indicated doses of gefitinib, erlotinib, afatinib, or AUY922 for 72 hours in medium containing 1% FBS. Cell viability was determined using the MTT assay.